RETRACTED: Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

This publication has 23 references indexed in Scilit:

• Add-on angiotensin receptor blockade with maximized ACE inhibition
  Kidney International, 2001
• Safety of the combination of valsartan and benazepril in patients with chronic renal disease
  Journal Of Hypertension, 2000
• Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
  The Lancet, 1999
• Combination ACE Inhibitor and Angiotensin II Receptor Antagonist Therapy in Diabetic Nephropathy
  American Journal of Nephrology, 1999
• Angiotensin-Converting Enzyme Inhibitors and Kidney Protection: The AIPRI Trial
  Journal of Cardiovascular Pharmacology, 1999
• Efficacy and Tolerability of Losartan in Hypertensive Patients With Renal Impairment
  Hypertension, 1998
• Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency
  New England Journal of Medicine, 1996
• A Randomized, Placebo-Controlled, Double-Blind, Parallel Study of Various Doses of Losartan Potassium Compared With Enalapril Maleate in Patients With Essential Hypertension
  Hypertension, 1995
• Long-term comparison between captopril and nifedipine in the progression of renal insufficiency
  Kidney International, 1992
• Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.
  Journal of Clinical Investigation, 1986